~~<i id='9A422FBADF'><strike id='9A422FBADF'><tt id='9A422FBADF'><pre id='9A422FBADF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：comprehensive 2025-10-02 14:39:21 - browse：4873

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Researchers test human milk's ability to repair gut microbiome

knowledge

focus

hotspot

focus

hotspot

AdobeTheFoodandDrugAdministrationhasclearedOtsukaPharmaceutical’sdigitaltreatmentformajordepressived

WSS

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

BridgeBio heart drug succeeds in pivotal study

Four alarming medical procedures we’re glad history forgot

Florida Supreme Court upholds state's abortion ban

Biden administration sends mixed signals on US soldier who crossed into North Korea

Study: Black kids more likely to die after surgery than white kids

focus

focus

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Drug companies' payments and gifts affect physicians' prescribing

Tori Bowie and the unacceptable rates of Black maternal death

Bird flu reported in person exposed to presumably infected cattle

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

United colonoscopy coverage change 'may cost lives,' doctors say

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

New air purifier tech could be key to improving indoor air quality

Alzheimer's risk factor APOE4 may be a distinct form of the disease

knowledge

Robert Kennedy Jr.'s presidential campaign attracts GOP

BridgeBio heart drug succeeds in pivotal study

Alzheimer's risk factor APOE4 may be a distinct form of the disease

More hospitals are billing patients as online messages surge

US soldier in North Korean custody after crossing DMZ line

Florida Supreme Court upholds state's abortion ban

focus

hotspot

focus

hotspot